Retension Pharmaceuticals Inc share price logo

Retension Pharmaceuticals Inc

NASDAQ: RTSN

$10.51

-2.50

(-19.22%)

as on

Retension Pharmaceuticals Inc Stock Performance

as on November 21, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $9.43
    $13.10
    downward going graph

    10.28%

    Downside

    24.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Retension Pharmaceuticals Inc share price movements today

Previous Close
$13.01
Open
$13.10
Volume
314.2K
Market Cap
$108.4M
Day's Low - High
$9.43 - $13.10

Retension Pharmaceuticals Inc Historical Returns

1 Month Return
-29.93 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Retension Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Retension Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$108.4M

EPS (TTM)

-2.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.00

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Retension Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Retension Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$108.4MNANA0.00%0.00%
Neutral$80.7B-26.07%-28.1528.00%0.00%
StrongBuy$45.7BNA65.0988.39%0.00%
StrongBuy$132.0B181.62%33.2585.53%0.00%
Buy$95.5B41.06%19.6585.77%0.41%

Analyst Recommendation on Retension Pharmaceuticals Inc Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Retension Pharmaceuticals Inc. Average target price of $52.5

Retension Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Retension Pharmaceuticals Inc.

Current Price

$10.51

Analyzed by

2 Analysts

High

$55

0

Low

$50

Retension Pharmaceuticals Inc target price $0, a slight upside of 0% compared to current price of $10.51. According to 2 analysts rating.

Indian Investors' Interest in Retension Pharmaceuticals Inc Stock

Search interest for Retension Pharmaceuticals Inc Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Retension Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2024
Dec 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-2
-6
EBITDA
-2
-6
Interest Expense
-
-
Depreciation
-
-
Income Before Tax
-1
-6
Income Tax Expense
-
-
Net Income
-1
-6
Net Profit Margin
0.00%
0.00%

Retension Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2025
Net Income
-6
Operating Cash Flow
-7
Investing Cash Flow
-
Financing Cash Flow
18
Change in Cash
10

Global Institutional Holdings in Retension Pharmaceuticals Inc

Check out the Institutions with significant holdings in Retension Pharmaceuticals Inc.

Funds
Holdings
Shares Held
Eric L. Keller
5.57%
464407
Paul Sweetnam
4.91%
409243
Vanguard
0.49%
40514
Franklin Berger
0.27%
22517
Michael Berendt
0.08%
6666

Insights on Retension Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, RTSN stock has moved down by -29.9%

About Retension Pharmaceuticals Inc

Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 inhibitor designed to reduce blood pressure by potentiating nitric oxide signaling, a key mechanism underlying the development and severity of hypertension. The company was founded by Eric Keller and Paul Sweetnam in 2023 and is headquartered in Falls Church, VA.
OrganisationRetension Pharmaceuticals Inc
Headquarters1104 West Broad Street 1029, Falls Church, VA, 22046, US
IndustryMedical - Pharmaceuticals
CEOEric L. Keller

Key Management of Retension Pharmaceuticals Inc

Name

Title

Ms. Sabine Bisson Ph.D.

Chief Operations Officer

Ms. LeAnne Bloedon M.S.

Executive Vice President of Clinical Development & Operations

Dr. Michael Joseph Berendt Ph.D.

Executive Chairman

Dr. Paul Sweetnam Ph.D.

Co-Founder, Chief Scientific Officer & Secretary

Mr. Alexander Duke Schwartz M.B.A.

Chief Financial Officer

Dr. Alison D. Schecter FACC, M.D.

Chief Medical Officer

Dr. Bridget McCarthy Cole Ph.D.

Head of CMC

Mr. Eric Keller J.D.

Co-founder, CEO & Director

Mr. Robert C. Wong

VP, Chief Accounting Officer & Principal Accounting Officer

Mr. Craig Michael Audet Ph.D.

Chief Regulatory & Compliance Officer

FAQs

What is Retension Pharmaceuticals Inc share price today?

Retension Pharmaceuticals Inc share price today is $10.51 as on at the close of the market. Retension Pharmaceuticals Inc share today touched a day high of $13.10 and a low of $9.43.

What is the 52 week high and 52 week low for Retension Pharmaceuticals Inc share?

Retension Pharmaceuticals Inc share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Retension Pharmaceuticals Inc stock price today i.e. is closed at $10.51,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Retension Pharmaceuticals Inc's market capitalisation today?

Retension Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Retension Pharmaceuticals Inc Stock (RTSN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Retension Pharmaceuticals Inc on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Retension Pharmaceuticals Inc Stock (RTSN) from India?

Indian investors can start investing in Retension Pharmaceuticals Inc (RTSN) shares with as little as ₹92.66000366210938 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.60 in Retension Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Retension Pharmaceuticals Inc share’s latest price of $10.51 as on November 21, 2026 at 8:46 am IST, you will get 0.9515 shares of Retension Pharmaceuticals Inc. Learn more about fractional shares .